Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial.

Donken R, Dobson SRM, Marty KD, Cook D, Sauvageau C, Gilca V, Dionne M, McNeil S, Krajden M, Money D, Kellner J, Scheifele DW, Kollmann T, Bettinger JA, Liu S, Singer J, Naus M, Sadarangani M, Ogilvie GS.

Clin Infect Dis. 2019 Sep 6. pii: ciz887. doi: 10.1093/cid/ciz887. [Epub ahead of print]

PMID:
31617568
2.

Cervical intraepithelial neoplasia rates in British Columbia women: A population level data linkage evaluation of the school-based HPV immunization program.

Racey CS, Albert A, Donken R, Smith L, Spinelli JJ, Pedersen H, de Bruin P, Masaro C, Mitchell-Foster S, Sadarangani M, Dawar M, Krajden M, Naus M, van Niekerk D, Ogilvie G.

J Infect Dis. 2019 Aug 23. pii: jiz422. doi: 10.1093/infdis/jiz422. [Epub ahead of print]

PMID:
31504649
3.

Measuring the impact of a mandatory province-wide vaccinate-or-mask policy on healthcare worker absenteeism in British Columbia, Canada.

Murti M, Otterstatter M, Orth A, Balshaw R, Halani K, Brown PD, Hejazi S, Thompson D, Allison S, Bharmal A, Dawar M, Hoyano D, Lee V, Naus M, Pollock S, Bevanda J, Coughlin S, Fitzgerald J, Keen D, Maracle M, Sprague S, Henry B.

Vaccine. 2019 Jul 9;37(30):4008-4014. doi: 10.1016/j.vaccine.2019.06.007. Epub 2019 Jun 14.

4.

Measuring the impact of influenza vaccination on healthcare worker absenteeism in the context of a province-wide mandatory vaccinate-or-mask policy.

Murti M, Otterstatter M, Orth A, Balshaw R, Halani K, Brown PD, Hejazi S, Thompson D, Allison S, Bharmal A, Dawar M, Hoyano D, Lee V, Naus M, Pollock S, Bevanda J, Coughlin S, Fitzgerald J, Keen D, Maracle M, Sprague S, Henry B.

Vaccine. 2019 Jul 9;37(30):4001-4007. doi: 10.1016/j.vaccine.2019.06.014. Epub 2019 Jun 14.

5.

Support for policy options to increase vaccination coverage in British Columbia, Canada: an electronic survey.

Bettinger JA, Greyson D, Carpiano R, de Bruin P, Aguiar I, Naus M, Hodson B.

CMAJ Open. 2019 Apr 23;7(2):E264-E271. doi: 10.9778/cmajo.20190034. Print 2019 Apr-Jun.

6.

Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.

Dodd CN, de Ridder M, Huang WT, Weibel D, Giner-Soriano M, Perez-Vilar S, Diez-Domingo J, Svenson LW, Mahmud SM, Carleton B, Naus M, Kwong JC, Murray BJ, Arnheim-Dahlstrom L, Pedersen L, Morros R, Puertas FJ, Black S, Sturkenboom M.

PLoS One. 2018 Oct 17;13(10):e0204799. doi: 10.1371/journal.pone.0204799. eCollection 2018.

7.

Population-level sexual behaviours in adolescent girls before and after introduction of the human papillomavirus vaccine (2003-2013).

Ogilvie GS, Phan F, Pedersen HN, Dobson SR, Naus M, Saewyc EM.

CMAJ. 2018 Oct 15;190(41):E1221-E1226. doi: 10.1503/cmaj.180628.

8.

Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.

Weibel D, Sturkenboom M, Black S, de Ridder M, Dodd C, Bonhoeffer J, Vanrolleghem A, van der Maas N, Lammers GJ, Overeem S, Gentile A, Giglio N, Castellano V, Kwong JC, Murray BJ, Cauch-Dudek K, Juhasz D, Campitelli M, Datta AN, Kallweit U, Huang WT, Huang YS, Hsu CY, Chen HC, Giner-Soriano M, Morros R, Gaig C, Tió E, Perez-Vilar S, Diez-Domingo J, Puertas FJ, Svenson LW, Mahmud SM, Carleton B, Naus M, Arnheim-Dahlström L, Pedersen L, DeStefano F, Shimabukuro TT.

Vaccine. 2018 Oct 1;36(41):6202-6211. doi: 10.1016/j.vaccine.2018.08.008. Epub 2018 Aug 16.

9.

Early use of the HPV 2-dose vaccination schedule: Leveraging evidence to support policy for accelerated impact.

Gilca V, Salmerón-Castro J, Sauvageau C, Ogilvie G, Landry M, Naus M, Lazcano-Ponce E.

Vaccine. 2018 Aug 6;36(32 Pt A):4800-4805. doi: 10.1016/j.vaccine.2018.02.004. Epub 2018 Jun 7.

10.

Diagnostic Yield of Laboratory Methods and Value of Viral Genotyping during an Outbreak of Mumps in a Partially Vaccinated Population in British Columbia, Canada.

Nunn A, Masud S, Krajden M, Naus M, Jassem AN.

J Clin Microbiol. 2018 Apr 25;56(5). pii: e01954-17. doi: 10.1128/JCM.01954-17. Print 2018 May.

11.

Implementing a province-wide mandatory vaccinate-or-mask policy at healthcare facilities in British Columbia, Canada.

Nunn A, Campbell AC, Naus M, Kwong JC, Puddicombe D, Quach S, Henry B.

Vaccine. 2018 Jan 8;36(3):395-399. doi: 10.1016/j.vaccine.2017.11.072. Epub 2017 Dec 6.

PMID:
29223487
12.

Methods used for immunization coverage assessment in Canada, a Canadian Immunization Research Network (CIRN) study.

Wilson SE, Quach S, MacDonald SE, Naus M, Deeks SL, Crowcroft NS, Mahmud SM, Tran D, Kwong J, Tu K, Gilbert NL, Johnson C, Desai S.

Hum Vaccin Immunother. 2017 Aug 3;13(8):1928-1936. doi: 10.1080/21645515.2017.1319022. Epub 2017 Jul 14.

13.

Immunization information systems in Canada: Attributes, functionality, strengths and challenges. A Canadian Immunization Research Network study.

Wilson SE, Quach S, MacDonald SE, Naus M, Deeks SL, Crowcroft NS, Mahmud SM, Tran D, Kwong JC, Tu K, Johnson C, Desai S.

Can J Public Health. 2017 Mar 1;107(6):e575-e582. doi: 10.17269/cjph.107.5679.

PMID:
28252378
14.

Will Infant Hepatitis B Vaccination Protect Into Adulthood?: Extended Canadian Experience After a 2-, 4- and 6-month Immunization Schedule.

Pinto M, Dawar M, Krajden M, Naus M, Scheifele DW.

Pediatr Infect Dis J. 2017 Jun;36(6):609-615. doi: 10.1097/INF.0000000000001543.

PMID:
28134742
15.

Vaccine acceptance, hesitancy and refusal in Canada: Challenges and potential approaches.

Dubé E, Bettinger JA, Fisher WA, Naus M, Mahmud SM, Hilderman T.

Can Commun Dis Rep. 2016 Dec 1;42(12):246-251. eCollection 2016 Dec 1.

16.

Assessing the risk of intussusception and rotavirus vaccine safety in Canada.

Hawken S, Ducharme R, Rosella LC, Benchimol EI, Langley JM, Wilson K, Crowcroft NS, Halperin SA, Desai S, Naus M, Sanford CJ, Mahmud SM, Deeks SL.

Hum Vaccin Immunother. 2017 Mar 4;13(3):703-710. doi: 10.1080/21645515.2016.1240846. Epub 2016 Nov 11.

17.

Whole-Genome Sequencing of Measles Virus Genotypes H1 and D8 During Outbreaks of Infection Following the 2010 Olympic Winter Games Reveals Viral Transmission Routes.

Gardy JL, Naus M, Amlani A, Chung W, Kim H, Tan M, Severini A, Krajden M, Puddicombe D, Sahni V, Hayden AS, Gustafson R, Henry B, Tang P.

J Infect Dis. 2015 Nov 15;212(10):1574-8. doi: 10.1093/infdis/jiv271. Epub 2015 Jul 6.

PMID:
26153409
18.

Outbreak of measles in an unvaccinated population, British Columbia, 2014.

Naus M, Puddicombe D, Murti M, Fung C, Stam R, Loadman S, Krajden M, Tang P, Lem M.

Can Commun Dis Rep. 2015 Jul 2;41(7):169-174. eCollection 2015 Jul 2.

19.

Listeriosis outbreaks in British Columbia, Canada, caused by soft ripened cheese contaminated from environmental sources.

McIntyre L, Wilcott L, Naus M.

Biomed Res Int. 2015;2015:131623. doi: 10.1155/2015/131623. Epub 2015 Mar 30.

20.

What do we know about how to improve vaccine uptake?

Naus M.

Can Commun Dis Rep. 2015 Apr 20;41(Suppl 3):6-10. eCollection 2015 Apr 20.

21.

Reduction in cervical intraepithelial neoplasia in young women in British Columbia after introduction of the HPV vaccine: An ecological analysis.

Ogilvie GS, Naus M, Money DM, Dobson SR, Miller D, Krajden M, van Niekerk DJ, Coldman AJ.

Int J Cancer. 2015 Oct 15;137(8):1931-7. doi: 10.1002/ijc.29508. Epub 2015 Jun 3.

22.

Behind the scenes in public health: Adverse events following immunization (AEFI) signal investigation in British Columbia.

MacDonald L, Naus M.

Can Commun Dis Rep. 2014 Dec 4;40(Suppl 3):24-30. eCollection 2014 Dec 4.

23.

Case series of rash associated with influenza B in school children.

Skowronski DM, Chambers C, Osei W, Walker J, Petric M, Naus M, Li Y, Krajden M.

Influenza Other Respir Viruses. 2015 Jan;9(1):32-7. doi: 10.1111/irv.12296. Epub 2014 Nov 10.

24.

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

Dobson SR, McNeil S, Dionne M, Dawar M, Ogilvie G, Krajden M, Sauvageau C, Scheifele DW, Kollmann TR, Halperin SA, Langley JM, Bettinger JA, Singer J, Money D, Miller D, Naus M, Marra F, Young E.

JAMA. 2013 May 1;309(17):1793-802. doi: 10.1001/jama.2013.1625.

PMID:
23632723
25.

Response to O'Brien et al.

Fisman DN, Lee V, Naus M.

Vaccine. 2013 Aug 12;31(36):3638-9. doi: 10.1016/j.vaccine.2013.04.020. Epub 2013 Apr 28. No abstract available.

PMID:
23628243
26.

Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation.

Fisman DN, Chan CH, Lowcock E, Naus M, Lee V.

Vaccine. 2012 Dec 14;30(52):7601-7. doi: 10.1016/j.vaccine.2012.10.034. Epub 2012 Oct 26.

PMID:
23107595
27.
28.

Optimizing Canadian public immunization programs: a prescription for action.

Scheifele DW, Naus M, Crowcroft NS, Dobson S, Halperin SA, Bjornson G.

Can J Public Health. 2011 May-Jun;102(3):193-5.

PMID:
21714317
29.

Immunization: a global challenge for the 21st Century.

Langley JM, Naus M.

Expert Rev Vaccines. 2011 Apr;10(4):429-31. doi: 10.1586/erv.11.34.

PMID:
21506640
30.

Mumps virus detection during an outbreak in a highly unvaccinated population in British Columbia.

Tan KE, Anderson M, Krajden M, Petric M, Mak A, Naus M.

Can J Public Health. 2011 Jan-Feb;102(1):47-50.

PMID:
21485966
31.

Influenza vaccination and intention to receive the pandemic H1N1 influenza vaccine among healthcare workers of British Columbia, Canada: a cross-sectional study.

Kaboli F, Astrakianakis G, Li G, Guzman J, Donovan T, Naus M.

Infect Control Hosp Epidemiol. 2010 Oct;31(10):1017-24. doi: 10.1086/655465. Erratum in: Infect Control Hosp Epidemiol. 2010 Dec;31(12):1316.

PMID:
20707670
32.

Physical and psychological abuse in breast cancer survivors and cancer-free women.

Canady BE, Naus MJ, Babcock JC.

J Psychosoc Oncol. 2010;28(4):351-60. doi: 10.1080/07347332.2010.485245.

PMID:
20623412
33.

A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt.

Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, Ehlen T, Dobson S, Money D, Patrick DM, Naus M.

PLoS Med. 2010 May 4;7(5):e1000270. doi: 10.1371/journal.pmed.1000270.

34.

A longitudinal investigation of coping and posttraumatic growth in breast cancer survivors.

Bussell VA, Naus MJ.

J Psychosoc Oncol. 2010;28(1):61-78. doi: 10.1080/07347330903438958.

PMID:
20391066
35.

Cancer survivor adaptation model: conceptualizing cancer as a chronic illness.

Naus MJ, Ishler MD, Parrott CE, Kovacs SA.

J Clin Psychol. 2009 Dec;65(12):1350-9. doi: 10.1002/jclp.20622.

PMID:
19827115
36.

Using single-system analyses to assess the effectiveness of an exercise intervention on quality of life for Hispanic breast cancer survivors: a pilot study.

Hughes DC, Leung P, Naus MJ.

Soc Work Health Care. 2008;47(1):73-91. doi: 10.1080/00981380801970871.

PMID:
18956514
37.

Protecting the next generation: what is the role of the duration of human papillomavirus vaccine-related immunity?

Günther OP, Ogilvie G, Naus M, Young E, Patrick DM, Dobson S, Duval B, Noël PA, Marra F, Miller D, Brunham RC, Pourbohloul B.

J Infect Dis. 2008 Jun 15;197(12):1653-61. doi: 10.1086/588140.

PMID:
18513154
38.

Intention of parents to have male children vaccinated with the human papillomavirus vaccine.

Ogilvie GS, Remple VP, Marra F, McNeil SA, Naus M, Pielak K, Ehlen T, Dobson S, Patrick DM, Money DM.

Sex Transm Infect. 2008 Aug;84(4):318-23. doi: 10.1136/sti.2007.029389. Epub 2008 Apr 29.

PMID:
18445636
39.

The burden of varicella and zoster in British Columbia 1994-2003: baseline assessment prior to universal vaccination.

Edgar BL, Galanis E, Kay C, Skowronski D, Naus M, Patrick D.

Can Commun Dis Rep. 2007 Nov 1;33(11):1-15. English, French. No abstract available.

40.

Bar coding vaccines - more than a 'check-out' issue.

Naus M.

Can J Infect Dis. 2000 Jul;11(4):173-4. No abstract available.

41.

Population-based surveillance of Hib invasive infections in children in British Columbia Alberta and Ontario - 1995 to 1997.

Scheifele D, Bell A, Jadavji T, Vaudry W, Waters J, Naus M, Sciberras J.

Can J Infect Dis. 2000 May;11(3):135-40.

42.

Parental intention to have daughters receive the human papillomavirus vaccine.

Ogilvie GS, Remple VP, Marra F, McNeil SA, Naus M, Pielak KL, Ehlen TG, Dobson SR, Money DM, Patrick DM.

CMAJ. 2007 Dec 4;177(12):1506-12.

43.

Population-based survey of travel patterns among Canadians visiting hepatitis A-endemic countries.

De Serres G, Duval B, Shadmani R, Rouleau I, Ouakki M, Naus M, Ward B.

J Travel Med. 2007 Jul-Aug;14(4):269-73. No abstract available.

44.

Comparison of trip characteristics of children and adults with travel-acquired hepatitis A infection.

Gosselin C, De Serres G, Rouleau I, Duval B, Shadmani R, Naus M, Ward BJ.

Pediatr Infect Dis J. 2006 Dec;25(12):1184-6.

PMID:
17133168
45.

Depression, implicit memory, and self: a revised memory model of emotion.

Barry ES, Naus MJ, Rehm LP.

Clin Psychol Rev. 2006 Oct;26(6):719-45. Epub 2005 Aug 18. Review.

PMID:
16111794
46.

The moderating effects of anxiety and breast cancer locus of control on depression.

Naus MJ, Price EC, Peter MP.

J Health Psychol. 2005 Sep;10(5):687-94.

PMID:
16033790
47.

Adult tetanus, diphtheria and pertussis immunization: knowledge, beliefs, behavior and anticipated uptake.

Skowronski DM, Pielak K, Remple VP, Halperin BA, Patrick DM, Naus M, McIntyre C.

Vaccine. 2004 Dec 2;23(3):353-61.

PMID:
15530680
48.

National eligible, due, and overdue guidelines for immunization registries: draft recommendations from the Canadian Immunization Registry Network, Data Standards Task Group.

Boulianne N, Hemon YA, Mawhinney T, Strong D, Gemmill I, Dobson S, Sartison E, Sargent M, Naus M, Tuchscherer R, Craig E, Watkins K, Schouten H; Canadian Immunization Registry Network, Data Standards Task Group.

Can Commun Dis Rep. 2004 Mar 15;30(6):53-9. English, French. No abstract available.

49.

Human rabies, British Columbia-January 2003.

Parker R, McKay D, Hawes C, Daly P, Bryce E, Doyle P, Moore W, McKenzie I, Roscoe D, Weatherill S, Skowronski DM, Petric M, Pielak K, Naus M.

Can Commun Dis Rep. 2003 Aug 15;29(16):137-8. English, French. No abstract available.

50.

Assessment of in-flight transmission of SARS--results of contact tracing, Canada.

Flint J, Burton S, Macey JF, Deeks SL, Tam TW, King A, Bodie-Collins M, Naus M, MacDonald D, McIntyre C, Krajden M, Petric M, Halpert C, Gustafson L, Larder A.

Can Commun Dis Rep. 2003 Jun 15;29(12):105-10. English, French. No abstract available.

Supplemental Content

Support Center